Abbot Financial Management’s Aspen Aerogels ASPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-30,180
Closed -$193K 131
2025
Q1
$193K Sell
30,180
-75
-0.2% -$723 0.1% 124
2024
Q4
$359K Buy
30,255
+1,146
+4% +$19.5K 0.18% 106
2024
Q3
$806K Buy
29,109
+3,893
+15% +$97.4K 0.41% 66
2024
Q2
$601K Sell
25,216
-9,600
-28% -$225K 0.32% 86
2024
Q1
$613K Buy
34,816
+6,712
+24% +$98.9K 0.34% 79
2023
Q4
$443K Hold
28,104
0.27% 94
2023
Q3
$242K Hold
28,104
0.16% 108
2023
Q2
$222K Sell
28,104
-2,568
-8% -$17.9K 0.14% 106
2023
Q1
$229K Buy
30,672
+19,660
+179% +$195K 0.15% 107
2022
Q4
$130K Buy
11,012
+189
+2% +$2.16K 0.09% 109
2022
Q3
$100K Buy
10,823
+10
+0.1% +$121 0.07% 108
2022
Q2
$107K Buy
10,813
+76
+0.7% +$1.53K 0.06% 121
2022
Q1
$370K Buy
10,737
+5,084
+90% +$165K 0.18% 100
2021
Q4
$281K Buy
+5,653
New +$298K 0.13% 116

Other funds holding ASPN

Abbot Financial Management's ASPN Position: Q2 2025 in Review

Abbot Financial Management sold out of Aspen Aerogels (ASPN) in Q2 2025, closing a stake of 30,180 shares — an estimated $193K sold.

Abbot Financial Management first reported a position in ASPN in Q4 2021 and held it in 14 quarters. The position peaked at $806K in Q3 2024. 182 funds tracked by Wall St. Rank hold ASPN as of Q2 2025.

  • Abbot Financial Management reported no remaining Aspen Aerogels position as of Q2 2025 after selling out during the quarter.
  • Abbot Financial Management sold 30,180 Aspen Aerogels shares in Q2 2025, an estimated $193K.
  • Abbot Financial Management first reported a position in Aspen Aerogels in Q4 2021 and held it in 14 quarters.
  • Abbot Financial Management's Aspen Aerogels position peaked at $806K in Q3 2024.
  • 182 funds tracked by Wall St. Rank held Aspen Aerogels as of Q2 2025.

Based on Abbot Financial Management's 13F filing for Q2 2025, filed 14 Aug 2025.